# Pilot Study of Neoantigen Peptides and Leukine for the Treatment of Neoplasms

> **NCT05475106** · EARLY_PHASE1 · RECRUITING · sponsor: **Instituto de Medicina Regenerativa** · enrollment: 100 (estimated)

## Conditions studied

- Neoplasms

## Interventions

- **BIOLOGICAL:** Neoantigen Peptides

## Key facts

- **NCT ID:** NCT05475106
- **Lead sponsor:** Instituto de Medicina Regenerativa
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-05-12
- **Primary completion:** 2025-11-25
- **Final completion:** 2026-06-20
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05475106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05475106, "Pilot Study of Neoantigen Peptides and Leukine for the Treatment of Neoplasms". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05475106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*